1. Home /
  2. Executive Interview

Executive Interview

Biotech Veru's Treatment Could Be a Game Changer, but What About the Stock?

Let's check out the charts of this biotech name.

Edwards Lifesciences Is Poised for Upside Breakout

Consider adding or going long above this critical price level.

An Updated Technical Strategy for Soaring Stitch Fix

The shares continued to climb northward after their gap early last week.

DexCom Shares Could Weaken Still Further in the Months Ahead

Investors continue to be more aggressive sellers of DXCM.

Chevron Could Use More Base Building Into 2021

Its charts indicate that the oil giant lacks aggressive buyers of its shares.

Hain Celestial's Base Could Support Further Price Gains

The shares have doubled from their March nadir.

Shares of Chewy Soar but Our Price Target Doesn't

Continue to hold new and existing CHWY longs.

APi Group Doesn't Present a Compelling Technical Case to Be a Buyer

Trading volume in the provider of commercial safety services has been light in recent months.

ServiceNow Could Trade Sideways Before the Next Leg Higher

Let's review the charts and indicators.

AZEK's Charts Are Building a Positive Looking Future

We do not have a lot of trading history to work with but what we do see so far is positive.